Scientific Advisory Board

To ensure a high quality of research is maintained over the long term, all Max Planck Institutes are subject to regular assessment from independent advisory boards. Their members are experts from leading international research institutions and universities. The Max Planck President elects them for a maximum term of six years following suggestions from the institutes.

Our institute's Scientific Advisory Board comprises the following 26 members:

• Prof. Dr. Julie Ahringer, 
  Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK
• Prof. Dr. David W. Chandler,
  Sandia National Laboratories, California, USA
• Prof. Dr. Francesca Ciccarelli,
  Cancer Systems Biology Laboratory, The Francis Crick Institute, London, UK
• Prof. Dr. Graeme Davis,
  Department of Biochemistry and Biophysics, University of California, San Francisco, USA
• Prof. Dr. Kristina Djinovic Carugo,
  European Molecular Biology Laboratory (EMBL), Grenoble, France
• Prof. Dr. Lucio Frydman,
  Department of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot, Israel
• Prof. Dr. Yukiko Goda, 
  Okinawa Institute of Science and Technology Graduate University, Okinawa, Japan
• Prof. Dr. Angela Gronenborn,
  Department of Structural Biology, University of Pittsburgh, Pennsylvania, USA
• Prof. Dr. Rebecca W. Heald,
  Department of Molecular & Cell Biology, University of California, Berkeley, USA
• Prof. Dr. Johan Hofkens,
  Molecular Imaging and Photonics, KU Leuven, Leuven, Belgium
• Prof. Dr. Laurinda Jaffe,
  School of Medicine, University of Connecticut, Connecticut, USA
• Prof. Dr. Franz X. Kärtner,
  Deutsches Elektronen-Synchrotron DESY, Hamburg, Germany
• Prof. Dr. Ute Kaiser,
  Electron Microscopy Group of Materials Science, Ulm University, Ulm, Germany
• Prof. Dr. Katrin Karbstein,
  Department of Biochemistry, Karbstein Lab, Vanderbilt University, Tennessee, USA
• Prof. Dr. Kinneret Keren,
  Physics Department, Technion – Israel Institute of Technology, Haifa, Israel
• Prof. Dr. Rob Klose,
  Department of Biochemistry, Oxford University, Oxford, UK
• Prof. Dr. Iain Mattaj, (CHAIR)
  Fondazione Human Technopole, Milan, Italy
• Prof. Dr. Steven McKnight,
  Department of Biochemistry, UT Southwestern Medical Center, Texas, USA
• Prof. Dr. Daniel M. Neumark,
  College of Chemistry, University of California, Berkeley, USA
• Prof. Dr. Arthur G. Palmer III,
  Department of Biochemistry and Molecular Biophysics, Columbia University, New York, USA
• Prof. Dr. Tatyana Polenova,
  Department of Chemistry and Biochemistry, University of Delaware, Delaware, USA
• Prof. Dr. Anna Marie Pyle,
  Dept. of Molecular, Cellular and Developmental Biology, Dept. of Chemistry, Yale University, Connecticut, USA
• Prof. Dr. Jeremy C. Smith, 
  Oak Ridge National Laboratory, Tennessee, USA
• Prof. Dr. Beth Stevens,
  Harvard Medical School, Boston Children’s Hospital, Massachusetts, USA
• Prof. Dr. Peter Tielemann,
  Department of Biological Sciences, Biocomputing Group, University of Calgary, Calgary, Canada
• Prof. Dr. Joachim Wittbrodt,
  Centre for Organismal Studies, Heidelberg University, Heidelberg, Germany